{"rows":[{"id":4197,"title":"Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.","authors":"Husein A, Traylor M, Vest MF, Wood BJ, Brogan M, Thomas A, McNeil S, Bhuiyan MAN, Hendricks P, Kelly JR, Gribben A, Al-Qahtani MM, Keys K, Edinoff AN, Patterson JC, Murnane KS","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251381806","pubmed_id":"42539773","openalex_id":"https://openalex.org/W7117566828","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539773/","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study,Safety","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42539773","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539773/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539773","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539773/","doi":"10.1177/28314425251381806","pmid":"42539773","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1990,"title":"Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.","authors":"Back AL, McGregor BA, Billingsley L, Blom D, Callan G, Myers S, Guy J, Kumar S, Layer M, Levin J, Perez J, Thompson P, Salmonson K, Whinney J, Thorn LL","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251404460","pubmed_id":"42539893","openalex_id":"https://openalex.org/W7116873484","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Emotional Processing,Clinical Trial,Cancer Patients,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42539893","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539893","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","doi":"10.1177/28314425251404460","pmid":"42539893","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":51,"title":"Balancing safety and access in Oregon’s psilocybin services","authors":"Cheung Katherine, Propes Caleigh, Yaden David B.","journal":"International Journal of Drug Policy","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1016/j.drugpo.2026.105384","pubmed_id":"42288041","openalex_id":"https://openalex.org/W7164654902","source_url":"https://doi.org/10.1016/j.drugpo.2026.105384","substance_tags":"psilocybin","topic_tags":"Safety","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"PMID:42288041","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.drugpo.2026.105384","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42288041","source_url":"https://doi.org/10.1016/j.drugpo.2026.105384","doi":"10.1016/j.drugpo.2026.105384","pmid":"42288041","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5875,"title":"JAMA study examines Oregon's psilocybin services model","authors":"Canady Valerie A.","journal":"Mental Health Weekly","publication_date":"2026-08-24","publication_year":2026,"doi":"10.1002/mhw.34984","pubmed_id":null,"openalex_id":"https://openalex.org/W7203871494","source_url":"https://doi.org/10.1002/mhw.34984","substance_tags":"psilocybin","topic_tags":"Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-08-22 01:20:15","last_checked":"2026-08-23 01:20:19","bibtex":null,"source_record_id":"DOI:10.1002/mhw.34984","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1002/mhw.34984","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1002/mhw.34984","source_url":"https://doi.org/10.1002/mhw.34984","doi":"10.1002/mhw.34984","pmid":"","publication_date":"2026-08-24","importer_version":"2.1.3","text_redistributed":false}},{"id":5876,"title":"Complex Fatal Self-Harm Under Psilocybin Intoxication: Suicidal Manner of Death or Not?","authors":"Labonté Caleb, Walker Alfredo E.","journal":"Academic Forensic Pathology","publication_date":"2026-08-21","publication_year":2026,"doi":"10.1177/19253621261468084","pubmed_id":null,"openalex_id":"https://openalex.org/W7203928864","source_url":"https://doi.org/10.1177/19253621261468084","substance_tags":"psilocybin,psilocin","topic_tags":"Safety","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-08-22 01:20:15","last_checked":"2026-08-23 01:20:19","bibtex":null,"source_record_id":"DOI:10.1177/19253621261468084","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1177/19253621261468084","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1177/19253621261468084","source_url":"https://doi.org/10.1177/19253621261468084","doi":"10.1177/19253621261468084","pmid":"","publication_date":"2026-08-21","importer_version":"2.1.3","text_redistributed":false}},{"id":5877,"title":"The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A Narrative Review","authors":"Clark Rachel N","journal":"Lynchburg Journal of Medical Science","publication_date":"2026-08-20","publication_year":2026,"doi":"10.63932/3067-7106.1087","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.63932/3067-7106.1087","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-08-22 01:20:15","last_checked":"2026-08-23 01:20:15","bibtex":null,"source_record_id":"DOI:10.63932/3067-7106.1087","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.63932/3067-7106.1087","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.63932/3067-7106.1087","source_url":"https://doi.org/10.63932/3067-7106.1087","doi":"10.63932/3067-7106.1087","pmid":"","publication_date":"2026-08-20","importer_version":"2.1.3","text_redistributed":false}},{"id":5872,"title":"Psilocybin in the Treatment of Methamphetamine Use Disorder","authors":"Peter Hendricks","journal":"ClinicalTrials.gov","publication_date":"2026-08-19","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07774702","substance_tags":"psilocybin","topic_tags":"Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-08-20 01:29:20","last_checked":"2026-08-23 01:23:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07774702","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07774702","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07774702","source_url":"https://clinicaltrials.gov/study/NCT07774702","doi":"","pmid":"","publication_date":"2026-08-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5870,"title":"Level of Preparedness to Use Psilocybin Among Individuals Seeking Psychedelic Risk Reduction: A retrospective study of a pilot psychiatric consultation service","authors":"Harrison, H. V.; Gaillard, M.; Cook, R. R.; Sarparast, A.; Levander, X. A.","journal":"medRxiv","publication_date":"2026-08-19","publication_year":2026,"doi":"10.64898/2026.08.17.26360633","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.08.17.26360633","substance_tags":"psilocybin","topic_tags":"Review Article,Safety,Adverse Events","study_type":"Review Article","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-08-20 01:20:38","last_checked":"2026-08-23 01:20:34","bibtex":null,"source_record_id":"DOI:10.64898/2026.08.17.26360633","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.08.17.26360633","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.08.17.26360633","source_url":"https://doi.org/10.64898/2026.08.17.26360633","doi":"10.64898/2026.08.17.26360633","pmid":"","publication_date":"2026-08-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5868,"title":"The subtle science: a systematic review of psilocybin magic mushroom and truffle microdosing","authors":"Page Jeni, Moore Alexandra, Hawkins Bridget E., Lyons Elizabeth J., Lorenzo Elizabeth","journal":"Frontiers in Psychiatry","publication_date":"2026-08-19","publication_year":2026,"doi":"10.3389/fpsyt.2026.1866881","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.3389/fpsyt.2026.1866881","substance_tags":"psilocybin","topic_tags":"Chronic Pain,Microdosing,Wellbeing,Creativity,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-08-20 01:20:15","last_checked":"2026-08-23 01:20:15","bibtex":null,"source_record_id":"DOI:10.3389/fpsyt.2026.1866881","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3389/fpsyt.2026.1866881","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3389/fpsyt.2026.1866881","source_url":"https://doi.org/10.3389/fpsyt.2026.1866881","doi":"10.3389/fpsyt.2026.1866881","pmid":"","publication_date":"2026-08-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5867,"title":"Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services","authors":"Korthuis P. Todd, Cook Ryan R., Gregoire Devin, Stauffer Christopher S., Luoma Jason B., Pertl Kellie, Des Jarlais Don, McCarty Dennis, Levander Ximena A., Hoffman Kim A., Wilson-Poe Adrianne R.","journal":"JAMA Network Open","publication_date":"2026-08-19","publication_year":2026,"doi":"10.1001/jamanetworkopen.2026.30608","pubmed_id":"42616497","openalex_id":"https://openalex.org/W7203781486","source_url":"https://doi.org/10.1001/jamanetworkopen.2026.30608","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Wellbeing,Observational Study,Veterans,Healthcare Workers,Safety","study_type":"Observational Study","source_name":"Crossref","publication_status":"published","date_added":"2026-08-20 01:20:15","last_checked":"2026-08-23 01:20:19","bibtex":null,"source_record_id":"PMID:42616497","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1001/jamanetworkopen.2026.30608","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42616497","source_url":"https://doi.org/10.1001/jamanetworkopen.2026.30608","doi":"10.1001/jamanetworkopen.2026.30608","pmid":"42616497","publication_date":"2026-08-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5719,"title":"Sex Differences in Acute Responses to Psychedelics: Evidence for Greater Subjective Intensity and Impairment in Female Participants","authors":"Mason, N. L.; Haijen-Bongers, E. C.; Kuypers, K. P. C.; Frick, A.; Toennes, S. W.; Mallaroni, P.; Ramaekers, J. G.","journal":"bioRxiv","publication_date":"2026-08-19","publication_year":2026,"doi":"10.64898/2026.07.08.737179","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.07.08.737179","substance_tags":"psilocybin","topic_tags":"Pharmacology,Mechanism of Action,Healthy Volunteers,Safety","study_type":"Clinical Trial","source_name":"bioRxiv","publication_status":"preprint","date_added":"2026-07-14 01:27:23","last_checked":"2026-08-21 01:26:27","bibtex":null,"source_record_id":"DOI:10.64898/2026.07.08.737179","abstract_available":true,"abstract_source":"bioRxiv","abstract_source_url":"https://doi.org/10.64898/2026.07.08.737179","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"bioRxiv","source_record_id":"DOI:10.64898/2026.07.08.737179","source_url":"https://doi.org/10.64898/2026.07.08.737179","doi":"10.64898/2026.07.08.737179","pmid":"","publication_date":"2026-08-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5869,"title":"The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent Studies","authors":"Michael J. Broman, Jhuma N. Acharya, Kaltum Ahmed, Stacey B. Armstrong, Alan K. Davis","journal":"Current Addiction Reports","publication_date":"2026-08-18","publication_year":2026,"doi":"10.1007/s40429-026-00774-8","pubmed_id":null,"openalex_id":"https://openalex.org/W7203711549","source_url":"https://doi.org/10.1007/s40429-026-00774-8","substance_tags":"psilocybin","topic_tags":"Clinical Trial,Review Article,Safety,Toxicity,Abuse Liability","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-20 01:20:19","last_checked":"2026-08-23 01:20:19","bibtex":null,"source_record_id":"DOI:10.1007/s40429-026-00774-8","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1007/s40429-026-00774-8","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s40429-026-00774-8","source_url":"https://doi.org/10.1007/s40429-026-00774-8","doi":"10.1007/s40429-026-00774-8","pmid":"","publication_date":"2026-08-18","importer_version":"2.1.3","text_redistributed":false}},{"id":3490,"title":"A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder","authors":"COMPASS Pathways","journal":"ClinicalTrials.gov","publication_date":"2026-08-18","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07570654","substance_tags":"psilocybin","topic_tags":"PTSD,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-08-23 01:23:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07570654","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07570654","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07570654","source_url":"https://clinicaltrials.gov/study/NCT07570654","doi":"","pmid":"","publication_date":"2026-08-18","importer_version":"2.1.3","text_redistributed":false}},{"id":5866,"title":"Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer Care","authors":"Christopher P. Albertyn, Ron Shore, Linda E. Carlson, Erika Dyck, David Clements","journal":null,"publication_date":"2026-08-17","publication_year":2026,"doi":"10.5281/zenodo.21983116","pubmed_id":null,"openalex_id":"https://openalex.org/W7203633773","source_url":"https://doi.org/10.5281/zenodo.21983116","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Mechanism of Action,Clinical Trial,Review Article,Healthcare Workers,Safety,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-19 01:20:25","last_checked":"2026-08-23 01:20:19","bibtex":null,"source_record_id":"DOI:10.5281/zenodo.21983116","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.5281/zenodo.21983116","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.5281/zenodo.21983116","source_url":"https://doi.org/10.5281/zenodo.21983116","doi":"10.5281/zenodo.21983116","pmid":"","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5865,"title":"Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks.","authors":"Strika-Bruneau L, Elhssaini C, Fauvel B, Kervadec E, Bezo A, Amirouche A, Benyamina A, Romeo B.","journal":"Journal of psychopharmacology (Oxford, England)","publication_date":"2026-08-17","publication_year":2026,"doi":"10.1177/02698811261473436","pubmed_id":"42609034","openalex_id":null,"source_url":"https://doi.org/10.1177/02698811261473436","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Wellbeing,Clinical Trial,Systematic Review,Review Article,Safety,Drug Interactions","study_type":"Systematic Review","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-19 01:20:04","last_checked":"2026-08-23 01:20:15","bibtex":null,"source_record_id":"PMID:42609034","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1177/02698811261473436","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42609034","source_url":"https://doi.org/10.1177/02698811261473436","doi":"10.1177/02698811261473436","pmid":"42609034","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5742,"title":"An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life","authors":"Charles Raison","journal":"ClinicalTrials.gov","publication_date":"2026-08-17","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07719088","substance_tags":"psilocybin,psilocin","topic_tags":"Neuroplasticity,Mechanism of Action,Biomarkers,Aging,Epigenetics,Cellular Senescence,Longevity,Oxidative Stress,Wellbeing,Clinical Trial,Observational Study,Animal Study,Older Adults,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-23 01:25:56","last_checked":"2026-08-23 01:23:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07719088","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07719088","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07719088","source_url":"https://clinicaltrials.gov/study/NCT07719088","doi":"","pmid":"","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5864,"title":"Subacute and long-term changes in cognitive functioning after administration of classic psychedelics, MDMA and ketamine: A systematic review of clinical and preclinical evidence.","authors":"Kelly C, Cooley BJ, Zeng L, Hurzeler T, Manning V, McNally GP, Watt J, Haber PS, Morley KC.","journal":"Neuroscience and biobehavioral reviews","publication_date":"2026-08-14","publication_year":2026,"doi":"10.1016/j.neubiorev.2026.106911","pubmed_id":"42600962","openalex_id":null,"source_url":"https://doi.org/10.1016/j.neubiorev.2026.106911","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Systematic Review,Review Article,Animal Study,Safety","study_type":"Systematic Review","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-16 01:20:05","last_checked":"2026-08-21 01:20:41","bibtex":null,"source_record_id":"PMID:42600962","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1016/j.neubiorev.2026.106911","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42600962","source_url":"https://doi.org/10.1016/j.neubiorev.2026.106911","doi":"10.1016/j.neubiorev.2026.106911","pmid":"42600962","publication_date":"2026-08-14","importer_version":"2.1.3","text_redistributed":false}},{"id":3626,"title":"The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults","authors":"Region Skane","journal":"ClinicalTrials.gov","publication_date":"2026-08-14","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07169747","substance_tags":"psilocybin","topic_tags":"Anxiety,Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Biomarkers,Aging,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Adolescents,Healthcare Workers,Safety,Adverse Events,Toxicity,Drug Interactions","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-21 01:27:47","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07169747","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07169747","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07169747","source_url":"https://clinicaltrials.gov/study/NCT07169747","doi":"","pmid":"","publication_date":"2026-08-14","importer_version":"2.1.3","text_redistributed":false}},{"id":3602,"title":"Safety for Home Administration of Microdose Psilocybin Use","authors":"Johns Hopkins University","journal":"ClinicalTrials.gov","publication_date":"2026-08-14","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06450210","substance_tags":"psilocybin","topic_tags":"Microdosing,Healthy Volunteers,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-21 01:27:46","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06450210","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06450210","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06450210","source_url":"https://clinicaltrials.gov/study/NCT06450210","doi":"","pmid":"","publication_date":"2026-08-14","importer_version":"2.1.3","text_redistributed":false}},{"id":3472,"title":"A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans","authors":"VA Office of Research and Development","journal":"ClinicalTrials.gov","publication_date":"2026-08-14","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07226232","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Randomized Controlled Trial,Treatment-Resistant Depression,Veterans,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-08-21 01:27:46","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07226232","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07226232","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07226232","source_url":"https://clinicaltrials.gov/study/NCT07226232","doi":"","pmid":"","publication_date":"2026-08-14","importer_version":"2.1.3","text_redistributed":false}}],"total":1211,"page":1,"per_page":20,"pages":61,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":"Safety","study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newest","page":1,"per_page":"20"}}